Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 23937266)

1.

Pathological characteristics of patients who develop hepatocellular carcinoma with negative results of both serous hepatitis B surface antigen and hepatitis C virus antibody.

Kondo R, Nakashima O, Sata M, Imazeki F, Yokosuka O, Tanikawa K, Kage M, Yano H; Liver Cancer Study Group of Kyushu.

Hepatol Res. 2014 Oct;44(11):1039-46. doi: 10.1111/hepr.12219. Epub 2013 Sep 17.

PMID:
23937266
2.

Mandibular metastasis as an initial manifestation of hepatocellular carcinoma: A report of two cases.

DU C, Feng Y, Li N, Wang K, Wang S, Gao Z.

Oncol Lett. 2015 Mar;9(3):1213-1216. Epub 2015 Jan 12.

3.

Time-dependent bias in hepatitis C classification.

Gillis J, Cooper C, Burchell AN, Gardner S, Manno M, Mazzulli T, Rourke SB, Raboud JM; OHTN Cohort Study Group.

Epidemiology. 2015 Mar;26(2):e24-6. doi: 10.1097/EDE.0000000000000255. No abstract available.

PMID:
25643117
4.

Patients with chronic hepatitis C without advanced fibrosis and hepatocellular carcinoma: a retrospective clinical-pathological study.

K-Kutala B, Bedossa P, Guedj J, Asselah T, Martinot-Peignoux M, Duval X, Marcellin P.

Dig Liver Dis. 2015 Apr;47(4):296-302. doi: 10.1016/j.dld.2014.12.010. Epub 2014 Dec 25.

PMID:
25596930
5.

Occult hepatitis B virus infection in hemodialysis patients in Japan.

Saijo T, Joki N, Inishi Y, Muto M, Saijo M, Hase H.

Ther Apher Dial. 2015 Apr;19(2):125-30. doi: 10.1111/1744-9987.12241. Epub 2014 Nov 3.

PMID:
25363685
6.

Are statins a remedy for all seasons?

Negro F.

J Hepatol. 2015 Jan;62(1):8-10. doi: 10.1016/j.jhep.2014.09.018. Epub 2014 Sep 20. No abstract available.

7.

Impact of occult hepatitis B virus infection on outcome after resection for non-B non-C hepatocellular carcinoma.

Wu ZF, Xu Z, Li WS, Zhang HB, Yang N, Yao XQ, Liu FK, Yang GS.

J Surg Res. 2015 Jan;193(1):153-60. doi: 10.1016/j.jss.2014.07.021. Epub 2014 Jul 21.

PMID:
25128925
8.

Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients.

Shibahara J, Ando S, Sakamoto Y, Kokudo N, Fukayama M.

Histopathology. 2014 Jun;64(7):951-62. doi: 10.1111/his.12343. Epub 2014 Feb 5.

PMID:
24898917
9.

Quantification of pregenomic RNA and covalently closed circular DNA in hepatitis B virus-related hepatocellular carcinoma.

Bai F, Yano Y, Fukumoto T, Takebe A, Tanaka M, Kuramitsu K, Anggorowati N, Rinonce HT, Widasari DI, Saito M, Hirano H, Hayakumo T, Seo Y, Azuma T, Ku Y, Hayashi Y.

Int J Hepatol. 2013;2013:849290. doi: 10.1155/2013/849290. Epub 2013 Dec 19.

10.

Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C.

Reddy A, May E, Ehrinpreis M, Mutchnick M.

World J Gastroenterol. 2013 Dec 28;19(48):9328-33. doi: 10.3748/wjg.v19.i48.9328.

11.

The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.

Zhang M, Wu R, Jiang J, Minuk GY, Niu J.

Alcohol. 2013 Nov;47(7):553-8. doi: 10.1016/j.alcohol.2013.07.003. Epub 2013 Sep 13.

PMID:
24041840
12.

Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection.

Nakano M, Kawaguchi T, Nakamoto S, Kawaguchi A, Kanda T, Imazeki F, Kuromatsu R, Sumie S, Satani M, Yamada S, Torimura T, Kakuma T, Yokosuka O, Sata M.

Oncol Rep. 2013 Nov;30(5):2049-55. doi: 10.3892/or.2013.2700. Epub 2013 Aug 27.

PMID:
23982634
13.

[Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].

Zhang RF, Liu L, Zheng YF, Shen YZ, Chen J, Gu SM, Wang JR, Lu HZ.

Zhonghua Gan Zang Bing Za Zhi. 2013 Mar;21(3):189-91. Chinese.

PMID:
23967739
14.

Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.

Squadrito G, Cacciola I, Alibrandi A, Pollicino T, Raimondo G.

J Hepatol. 2013 Oct;59(4):696-700. doi: 10.1016/j.jhep.2013.05.043. Epub 2013 Jun 7. Erratum in: J Hepatol. 2014 Jan;60(1):238.

PMID:
23751755
15.

Occult hepatitis B virus infection among Egyptian blood donors.

Said ZN, Sayed MH, Salama II, Aboel-Magd EK, Mahmoud MH, Setouhy ME, Mouftah F, Azzab MB, Goubran H, Bassili A, Esmat GE.

World J Hepatol. 2013 Feb 27;5(2):64-73. doi: 10.4254/wjh.v5.i2.64.

16.

Relation between antibody to hepatitis B core antigen and survival after curative therapy for non-B non-C hepatocellular carcinoma.

Nishikawa H, Osaki Y, Arimoto A, Kita R, Kimura T.

Anticancer Res. 2013 May;33(5):2211-9.

PMID:
23645778
17.

Lack of correlation between the antibody to hepatitis B core antigen and survival after surgical resection for hepatitis C virus-related hepatocellular carcinoma.

Nishikawa H, Arimoto A, Wakasa T, Kita R, Kimura T, Osaki Y.

Oncol Rep. 2013 Jul;30(1):91-8. doi: 10.3892/or.2013.2422. Epub 2013 Apr 24.

PMID:
23615658
18.

Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B.

Mathai AM, Alexander J, Kuo FY, Torbenson M, Swanson PE, Yeh MM.

Hum Pathol. 2013 Aug;44(8):1665-71. doi: 10.1016/j.humpath.2013.01.020. Epub 2013 Apr 8.

PMID:
23574780
19.

Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women.

Khamduang W, Ngo-Giang-Huong N, Gaudy-Graffin C, Jourdain G, Suwankornsakul W, Jarupanich T, Chalermpolprapa V, Nanta S, Puarattana-Aroonkorn N, Tonmat S, Lallemant M, Goudeau A, Sirirungsi W; Program for HIV Prevention and Treatment (PHPT-2) group.

Clin Infect Dis. 2013 Jun;56(12):1704-12. doi: 10.1093/cid/cit166. Epub 2013 Mar 13.

20.

Features and outcome after liver resection for non-B non-C hepatocellular carcinoma.

Kaneda K, Kubo S, Tanaka H, Takemura S, Ohba K, Uenishi T, Kodai S, Shinkawa H, Urata Y, Sakae M, Yamamoto T, Suehiro S.

Hepatogastroenterology. 2012 Sep;59(118):1889-92. doi: 10.5754/hge10778.

PMID:
22819910
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk